Similar articles

Abstract: fulminant type 1 diabetes is a recently discovered subtype of idiopathic type 1 diabetes, defined as diabetes with an extremely rapid process of β-cell destruction and progression to hyperglycemia and ketoacidosis. In this report, we present a case of fulminant type 1 diabetes in a 45-year-old Chinese woman, along with a review of the literature. The patient presented with sudden onset of polydipsia and polyuria after flu-like symptoms. Findings on admission included a high blood glucose level and ketoacidosis, but normal HbA1c level. The C-peptide stimulation test showed severe impairment of insulin secretion. Autoantibodies to glutamic acid decarboxylase (GAD) were negative. These results are compatible with the diagnosis of fulminant type 1 diabetes. Human leukocyte antigen-DR7 (HLA-DR7) was available in this case. It is concluded that this rapidly progressing type of diabetes exists, and we propose that HLA-DR7 might be predisposed to fulminant type 1 diabetes in Chinese patients.

[1]Akatsuka, H., Yano, Y., Gabazza, E.C., Morser, J., Sasaki, R., Suzuki, T., Fujiwara, R., Katsuki, A., Takei, Y., Sumida, Y., 2009. A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody. Diabetes Res. Clin. Pract., 84(3):e50-e52.

[2]Cho, Y.M., Kim, J.T., Ko, K.S., Koo, B.K., Yang, S.W., Park, M.H., 2007. Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Diabetologia, 50(11):2276-2279.

[3]Goto, A., Takahashi, Y., Kishimoto, M., Nakajima, Y., Nakanishi, K., Kajio, H., Noda, M., 2008. A case of fulminant type 1 diabetes associated with significant elevation of mumps titers. Endocr. J., 55(3):561-564.

[4]Hanafusa, T., Imagawa, A., 2007. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nature clinical practice. Endocrinol. Metabol., 3(1):36-45.

[5]Imagawa, A., Hanafusa, T., 2006. Pathogenesis of fulminant type1 diabetes. Rev. Diabet. Stud., 3(4):169-177.

[6]Imagawa, A., Hanafusa, T., Miyagawa, J., Matsuzawa, Y., Osaka IDDM Study Group, 2000. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N. Engl. J. Med., 342(5):301-307.

[7]Imagawa, A., Hanafusa, T., Uchigata, Y., Kanatsuka, A., Kawasaki, E., Kobayashi, T., Shimada, A., 2003. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care, 26(8):2345-2352.

[8]Imagawa, A., Hanafusa, T., Uchigata, Y., Kanatsuka, A., Kawasaki, E., Kobayashi, T., Shimada, A., Shimizu, I., Maruyama, T., Makino, H., 2005. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia, 48(2):294-300.

[9]Kawabata, Y., Ikegami, H., Awata, T., Imagawa, A., Maruyama, T., Kawasaki, E., Tanaka, S., Shimada, A., Osawa, H., Kobayashi, T., et al., 2009. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia, 52(12):2513-2521.

[10]Kawasaki, E., Eguchi, K., 2006. Genetics of fulminant type 1 diabetes. Ann. N. Y. Acad. Sci., 1079(1):24-30.

[11]Kawasaki, E., Imagawa, A., Makino, H., Uga, M., Abiru, N., Hanafusa, T., Uchigata, Y., Eguchi, K., 2008. Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. Diabetes Care, 31(8):1608-1610.

[12]Moreau, C., Drui, D., Arnault-Ouary, G., Charbonnel, B., Chaillous, L., Cariou, B., 2008. Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab., 34(5):529-532.

[13]Nagata, M., Moriyama, H., Kotani, R., Yasuda, H., Kishi, M., Kurohara, M., Hara, K., Yokono, K., 2007. Immunological aspects of ‘fulminant type 1 diabetes’. Diabetes Res. Clin. Pract., 77(3):S99-S103.

[14]Sano, H., Terasaki, J., Tsutsumi, C., Imagawa, A., Hanafusa, T., 2008. A case of fulminant type 1 diabetes mellitus after influenza B infection. Diabetes Res. Clin. Pract., 79(3):e8-e9.

[15]Tanaka, S., Nishida, Y., Aida, K., Maruyama, T., Shimada, A., Suzuki, M., Shimura, H., Takizawa, S., Takahashi, M., Akiyama, D., et al., 2009. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes, 58(10):2285-2291.

[16]Zhang, Y.J., Wen, D., 2008. Treatment of five cases of fulminant type 1 diabetes. Chin. J. Gen. Pract., 6(9):950 (in Chinese).

[17]Zhou, J., Jia, W.P., Bao, Y.Q., Lu, W., Lu, J.Q., Li, Q., Liu, F., Wu, S.H., Xiang, K.S., 2007. A case of fulminant type 1 diabetes with rhabdomyolysis. Chin. J. Intern. Med., 46(11):944-945 (in Chinese).